Eileen Koutnik-Fotopoulos

Targeting Sweat: Treating Hyperhidrosis
03/29/2016
David Pariser, MD, FAAD, FACP, discusses treatment approaches for individuals living with hyperhidrosis.
David Pariser, MD, FAAD, FACP, discusses treatment approaches for individuals living with hyperhidrosis.
David Pariser, MD, FAAD, FACP,...
03/29/2016
The Dermatologist
Therapies for Managing Psoriasis
06/10/2015
An increased understanding of psoriasis pathophysiology has led to the release of new treatment targets.
An increased understanding of psoriasis pathophysiology has led to the release of new treatment targets.
An increased understanding of...
06/10/2015
First Report Managed Care
Obesity Management Requires an Individualized Approach
09/22/2014
New Orleans—Data from the National Health and Nutrition Examination Survey (NHANES) estimate that 69% of US adults are overweight or obese and approximately 17% of US children 2 to 19 years of age are obese. The economic impact of the obesity...
New Orleans—Data from the National Health and Nutrition Examination Survey (NHANES) estimate that 69% of US adults are overweight or obese and approximately 17% of US children 2 to 19 years of age are obese. The economic impact of the obesity...
New Orleans—Data from the...
09/22/2014
First Report Managed Care
Vilazodone Well Tolerated in Treatment of MDD
12/17/2012
San Diego—Data from 2 pivotal trials of 891 patients demonstrated that vilazodone was significantly superior to placebo on all depression rating scales tested, according to results presented during a poster session at the Psych Congress. The...
San Diego—Data from 2 pivotal trials of 891 patients demonstrated that vilazodone was significantly superior to placebo on all depression rating scales tested, according to results presented during a poster session at the Psych Congress. The...
San Diego—Data from 2 pivotal...
12/17/2012
First Report Managed Care
Mutations May Improve Ovarian Cancer Survival
04/25/2012
Among women with epithelial ovarian cancer (EOC), patients having a germline mutation in BRCA1 or BRCA2 was associated with improved 5-year overall survival, with BRCA2 carriers having the best prognosis, according to study results published...
Among women with epithelial ovarian cancer (EOC), patients having a germline mutation in BRCA1 or BRCA2 was associated with improved 5-year overall survival, with BRCA2 carriers having the best prognosis, according to study results published...
Among women with epithelial...
04/25/2012
First Report Managed Care
Conference Insider
Treatment Options for MS Continue to Evolve
07/13/2015
Multiple sclerosis (MS) is an autoimmune, chronic inflammatory neuro- degenerative disorder of the central nervous system (CNS).
Multiple sclerosis (MS) is an autoimmune, chronic inflammatory neuro- degenerative disorder of the central nervous system (CNS).
Multiple sclerosis (MS) is an...
07/13/2015
First Report Managed Care
News Connection
TNF-α Antagonist Use in Autoimmune Diseases
03/16/2012
Tumor necrosis factor (TNF)-α antagonists have proven successful in the treatment of autoimmune diseases; however, there have been concerns about the safety of these biologic drugs. New research found that the overall initiation of TNF-α...
Tumor necrosis factor (TNF)-α antagonists have proven successful in the treatment of autoimmune diseases; however, there have been concerns about the safety of these biologic drugs. New research found that the overall initiation of TNF-α...
Tumor necrosis factor (TNF)-α...
03/16/2012
First Report Managed Care
Specialty Drugs: The Tipping Point is Coming
02/02/2016
Payer clients are faced with alarmingly high-cost specialty drug trends with no clear direction on how to balance the dilemma of therapy versus cost. Add the explosive development of new specialty drugs over the next few years and payers...
Payer clients are faced with alarmingly high-cost specialty drug trends with no clear direction on how to balance the dilemma of therapy versus cost. Add the explosive development of new specialty drugs over the next few years and payers...
Payer clients are faced with...
02/02/2016
First Report Managed Care
News
Biologics: Changing the Treatment Scope for Psoriasis and Psoriatic Arthritis
12/15/2014
Biologic agents have altered the treatment landscape in the management of moderate-to-severe psoriasis and psoriatic arthritis.
Biologic agents have altered the treatment landscape in the management of moderate-to-severe psoriasis and psoriatic arthritis.
Biologic agents have altered the...
12/15/2014
First Report Managed Care
Monitoring Treatment Response in Colorectal Cancer
03/18/2014
Despite multidisciplinary and multimodality approaches to the management of colorectal cancer (CRC), there is an increasing need to define how clinicians monitor response to novel therapies in this patient population. Monitoring how disease...
Despite multidisciplinary and multimodality approaches to the management of colorectal cancer (CRC), there is an increasing need to define how clinicians monitor response to novel therapies in this patient population. Monitoring how disease...
Despite multidisciplinary and...
03/18/2014
First Report Managed Care

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use